Staging lymph nodes and blood at diagnosis in mycosis fungoides identifies patients at increased risk of progression to advanced stage: A retrospective cohort study.
Pamela Blair AllenAshley A McCook-VealJeffrey M SwitchenkoDarina M PaulinoTim NiyogusabaKatelin M BairdErica S TarabadkarMary Jo LechowiczPublished in: Cancer (2022)
Staging and baseline laboratory assessments with imaging, peripheral blood flow cytometry, TCR data, and LDH in patients who have newly diagnosed MF may identify those who are at risk for progression to advanced stage.
Keyphrases
- newly diagnosed
- lymph node
- flow cytometry
- peripheral blood
- end stage renal disease
- high resolution
- ejection fraction
- chronic kidney disease
- pet ct
- prognostic factors
- regulatory t cells
- big data
- genome wide
- electronic health record
- sentinel lymph node
- photodynamic therapy
- dna methylation
- patient reported outcomes
- mass spectrometry
- fluorescence imaging